(3-(4-(4-cyclopropylbenzyloxy)-3-methoxyphenyl)azetidin-1-yl)(4-(2-(4-methylpiperazin-1-yl)ethoxy)pyridin-2-yl)methanone

ID: ALA4452717

Chembl Id: CHEMBL4452717

PubChem CID: 49805999

Max Phase: Preclinical

Molecular Formula: C33H40N4O4

Molecular Weight: 556.71

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1cc(C2CN(C(=O)c3cc(OCCN4CCN(C)CC4)ccn3)C2)ccc1OCc1ccc(C2CC2)cc1

Standard InChI:  InChI=1S/C33H40N4O4/c1-35-13-15-36(16-14-35)17-18-40-29-11-12-34-30(20-29)33(38)37-21-28(22-37)27-9-10-31(32(19-27)39-2)41-23-24-3-5-25(6-4-24)26-7-8-26/h3-6,9-12,19-20,26,28H,7-8,13-18,21-23H2,1-2H3

Standard InChI Key:  VZQKVKDEIOKDHI-UHFFFAOYSA-N

Associated Targets(Human)

CSF1R Tclin Macrophage colony stimulating factor receptor (5179 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Csf1r Macrophage colony-stimulating factor 1 receptor (491 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mus musculus (284745 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 556.71Molecular Weight (Monoisotopic): 556.3050AlogP: 4.41#Rotatable Bonds: 11
Polar Surface Area: 67.37Molecular Species: NEUTRALHBA: 7HBD: 0
#RO5 Violations: 1HBA (Lipinski): 8HBD (Lipinski): 0#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 7.75CX LogP: 3.84CX LogD: 3.33
Aromatic Rings: 3Heavy Atoms: 41QED Weighted: 0.35Np Likeness Score: -0.92

References

1. Ikegashira K, Ikenogami T, Yamasaki T, Oka T, Hase Y, Miyagawa N, Inagaki K, Kawahara I, Koga Y, Hashimoto H..  (2019)  Optimization of an azetidine series as inhibitors of colony stimulating factor-1 receptor (CSF-1R) Type II to lead to the clinical candidate JTE-952.,  29  (7): [PMID:30755337] [10.1016/j.bmcl.2019.02.006]

Source